Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Clinical Immunology · Immunodeficiency 99

Diagnosis and Lab Tests for IMD99

At a Glance

IMD99 diagnosis requires a combination of tests, not one result: doctors review antibody levels and blood counts, assess vaccine responses and immune-cell patterns, and use genetic testing while checking for other causes of low antibodies. This helps explain infection risk and autoimmune cytopenias.

Diagnosing Immunodeficiency 99 (IMD99) is a bit like solving a complex puzzle. While many people are familiar with Common Variable Immunodeficiency (CVID)—a clinical diagnosis made using defined immunoglobulin and functional-response findings after excluding secondary causes—IMD99 is a more specific, “gene-defined” diagnosis [1][2]. Some patients with monogenic disease have a CVID-like phenotype.

Getting a precise diagnosis through genetic testing and detailed blood work is vital. It moves you from a clinical category into a specific one, which helps your doctors understand exactly why your immune system is both underactive and overactive [1][3]. Your doctor will also perform a secondary-cause review to ensure your hypogammaglobulinemia isn’t caused by medication exposure, protein loss, hematologic malignancy, renal or gastrointestinal disease, or recent transfusion.

Essential Laboratory Tests

Your doctors use three “layers” of testing to monitor your health and refine your diagnosis.

Layer 1: The Foundation (CBC and Basic Immunoglobulins)

  • Complete Blood Count (CBC) with Differential: This is the most common test. It counts your red blood cells, white blood cells, and platelets [4]. In IMD99, doctors use this to track autoimmune cytopenias (low blood counts caused by immune attack) [5].
  • Quantitative Immunoglobulins (IgG, IgA, IgM): These measure the total amount of different antibody types in your blood [6]. Low levels of these, especially IgG, explain why you may get frequent infections [7].
  • Coombs Test (Direct Antiglobulin Test or DAT): This specific test looks for antibodies that are stuck to the surface of your red blood cells [8]. A positive DAT does not by itself prove active autoimmune hemolytic anemia; it can occur without hemolysis (including after transfusion or IgRT). Conversely, a negative test does not completely exclude hemolysis. Doctors pair DAT interpretation with hemoglobin trend, reticulocyte count, bilirubin, LDH, haptoglobin, and blood-film findings [9].

Layer 2: Functional Testing (Vaccine Responses)

Having antibodies is one thing; having antibodies that work is another. Doctors perform vaccine challenge tests to see if your body can produce new, protective antibodies after a shot (like the pneumonia or tetanus vaccine) [10][11]. Note that pneumococcal and tetanus titers require age-, assay-, vaccine-, and timing-specific interpretation and can be confounded by IVIG therapy; they do not by themselves “confirm” a functional deficiency [11].

Layer 3: Advanced Mapping (Immunophenotyping)

This advanced test, often done via flow cytometry, acts like a “map” of your immune cells [12]. It looks at specific subsets of cells:

  • Switched Memory B Cells: If these are low, it may be associated with B-cell “factories” struggling to mature and remember past germs [13].
  • CD21-low B Cells: High levels of these specific cells are sometimes associated with immune dysregulation and are frequently seen in patients who have autoimmune issues alongside their immunodeficiency [13][14].
  • Regulatory T Cells (Tregs): These are the “peacekeeper” cells. Routine measurement of Treg number does not establish Treg function, but they are an important part of the research into immune dysregulation [15].

Genetic Testing

While blood tests show what is happening, genetic testing attempts to show why. By sequencing your DNA, doctors look for the specific mutation that causes IMD99 [1]. However, genetic sequencing is not universally the “final answer”: it can be negative, identify a variant of uncertain significance (VUS), or require segregation and functional evidence [16][17]. Genetic counseling is highly recommended to interpret inheritance and family testing.


Your Lab Completeness Checklist

When you review your medical portal or talk to your doctor, ensure these key values have been discussed:

Category Key Values to Look For
Antibody Levels IgG, IgA, IgM (Total levels)
Blood Counts Hemoglobin, Platelets, Absolute Neutrophil Count (ANC)
Cell Subsets B Cells (Naïve vs. Switched Memory), T Cells (CD4+, CD8+), NK Cells
Autoimmune Markers Direct Coombs Test (DAT), Reticulocyte count, LDH, Haptoglobin
Function Pneumococcal titers (Pre- and Post-vaccination)
Genetics Genetic sequencing report and genetic counseling

Note: Always interpret these results with your immunology specialist, as “normal” ranges can vary based on your age and whether you are currently receiving immunoglobulin therapy [10][18]. Not every item in the checklist is required for every patient.

Common questions in this guide

What tests help diagnose IMD99?
Doctors usually combine a complete blood count, quantitative IgG, IgA, and IgM levels, vaccine-antibody testing, immune-cell testing by flow cytometry, and genetic sequencing. They also review medicines, protein loss, kidney or gastrointestinal disease, blood cancers, and recent transfusions as possible secondary causes of low antibody levels.
What does low IgG mean in IMD99?
Low IgG is called hypogammaglobulinemia and may make infections more frequent. It supports an antibody problem but does not by itself prove IMD99, because medicines, protein loss, other diseases, or recent transfusion can also affect antibody levels. Doctors interpret the result using age-specific ranges and the rest of the immune evaluation.
Can a Coombs test show whether IMD99 is attacking my red blood cells?
The direct antiglobulin test, also called a Coombs test, detects antibodies or related proteins attached to red blood cells. A positive result does not prove active red-cell destruction, and a negative result does not completely rule it out. Doctors compare it with hemoglobin trends, reticulocyte count, bilirubin, LDH, haptoglobin, and blood-film findings.
How do vaccine antibody tests measure immune function in IMD99?
Doctors may check pneumococcal or tetanus antibody levels before and after vaccination to see whether the body makes a protective response. Results depend on age, the laboratory method, the vaccine, and timing, and IVIG can interfere with interpretation. Vaccine titers alone do not confirm a functional antibody deficiency.
What do switched-memory and CD21-low B-cell results mean?
Flow cytometry can show how different B-cell groups are distributed. Low switched-memory B cells may suggest difficulty developing immune memory, while higher CD21-low B cells are associated with immune dysregulation and autoimmune problems. These patterns help clinicians assess the immune system but do not establish IMD99 on their own.
Can genetic testing be inconclusive for IMD99?
Yes. Sequencing may find no clearly harmful change or may report a variant of uncertain significance, which cannot by itself confirm the diagnosis. Doctors may use family testing, functional evidence, clinical findings, and genetic counseling to interpret the result.
What is the absolute neutrophil count, and why is it important?
The absolute neutrophil count, or ANC, measures the number of neutrophils available to help fight infection. A low ANC can increase the risk of bacterial infections, so clinicians track it with the rest of the blood count and your infection history.

Get notified when new evidence is published on immunodeficiency 99 with hypogammaglobulinemia and autoimmune cytopenias.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (18)
  1. 1

    There is no gene for CVID - novel monogenetic causes for primary antibody deficiency.

    Ramirez NJ, Posadas-Cantera S, Caballero-Oteyza A, et al.

    Current opinion in immunology 2021; (72()):176-185 doi:10.1016/j.coi.2021.05.010.

    PMID: 34153571
  2. 2

    Perspective: Application of the American College of Medical Genetics Variant Interpretation Criteria to Common Variable Immunodeficiency Disorders.

    Ameratunga R, Allan C, Lehnert K, Woon ST

    Clinical reviews in allergy & immunology 2021; (61(2)):226-235 doi:10.1007/s12016-020-08828-z.

    PMID: 33818703
  3. 3

    "Common variable immunodeficiency: Challenges for diagnosis".

    Wang LA, Abbott JK

    Journal of immunological methods 2022; (509()):113342 doi:10.1016/j.jim.2022.113342.

    PMID: 36027932
  4. 4

    Peripheral-blood cytopenia, an early indicator of inborn errors of immunity.

    Cornelissen HM, Musekwa EM, Glashoff RH, et al.

    British journal of haematology 2022; (198(5)):875-886 doi:10.1111/bjh.18337.

    PMID: 35791731
  5. 5

    Immune cytopenias as a continuum in inborn errors of immunity: An in-depth clinical and immunological exploration.

    Zama D, Conti F, Moratti M, et al.

    Immunity, inflammation and disease 2021; (9(2)):583-594 doi:10.1002/iid3.420.

    PMID: 33838017
  6. 6

    Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia.

    Gaál Z, Meehan C, Yilmaz M, et al.

    Pediatric blood & cancer 2026; (73(3)):e70074 doi:10.1002/1545-5017.70074.

    PMID: 41560547
  7. 7

    Immunoglobulin replacement therapy in primary and secondary antibody deficiency: The correct clinical approach.

    Pecoraro A, Crescenzi L, Granata F, et al.

    International immunopharmacology 2017; (52()):136-142 doi:10.1016/j.intimp.2017.09.005.

    PMID: 28898770
  8. 8

    Autoimmune Cytopenias in Common Variable Immunodeficiency Are a Diagnostic and Therapeutic Conundrum: An Update.

    Chawla S, Barman P, Tyagi R, et al.

    Frontiers in immunology 2022; (13()):869466 doi:10.3389/fimmu.2022.869466.

    PMID: 35795667
  9. 9

    Dual Autoimmunity: Evans Syndrome and Multiple Sclerosis.

    Markl A, Warren M, Iskander J, et al.

    Cureus 2026; (18(8)):e113997 doi:10.7759/cureus.113997.

    PMID: 42698986
  10. 10

    How to use immunoglobulin levels in investigating immune deficiencies.

    Ladomenou F, Gaspar B

    Archives of disease in childhood. Education and practice edition 2016; (101(3)):129-35 doi:10.1136/archdischild-2015-309060.

    PMID: 26987724
  11. 11

    Tonsillar granuloma associated with hypogammaglobulinemia.

    Laajala A, Kuismin O, Tastula M, et al.

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2020; (16()):43 doi:10.1186/s13223-020-00441-1.

    PMID: 32514274
  12. 12

    EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System.

    van Dongen JJM, van der Burg M, Kalina T, et al.

    Frontiers in immunology 2019; (10()):1271 doi:10.3389/fimmu.2019.01271.

    PMID: 31263462
  13. 13

    Predominantly Antibody-Deficient Patients With Non-infectious Complications Have Reduced Naive B, Treg, Th17, and Tfh17 Cells.

    Edwards ESJ, Bosco JJ, Aui PM, et al.

    Frontiers in immunology 2019; (10()):2593 doi:10.3389/fimmu.2019.02593.

    PMID: 31803177
  14. 14

    The TH1 phenotype of follicular helper T cells indicates an IFN-γ-associated immune dysregulation in patients with CD21low common variable immunodeficiency.

    Unger S, Seidl M, van Schouwenburg P, et al.

    The Journal of allergy and clinical immunology 2018; (141(2)):730-740 doi:10.1016/j.jaci.2017.04.041.

    PMID: 28554560
  15. 15

    Chronically Activated T-cells Retain Their Inflammatory Properties in Common Variable Immunodeficiency.

    Berbers RM, van der Wal MM, van Montfrans JM, et al.

    Journal of clinical immunology 2021; (41(7)):1621-1632 doi:10.1007/s10875-021-01084-6.

    PMID: 34247288
  16. 16

    Next-generation sequencing for inborn errors of immunity.

    Lee K, Abraham RS

    Human immunology 2021; (82(11)):871-882 doi:10.1016/j.humimm.2021.02.011.

    PMID: 33715910
  17. 17

    Evaluating the Genetics of Common Variable Immunodeficiency: Monogenetic Model and Beyond.

    de Valles-Ibáñez G, Esteve-Solé A, Piquer M, et al.

    Frontiers in immunology 2018; (9()):636 doi:10.3389/fimmu.2018.00636.

    PMID: 29867916
  18. 18

    Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab.

    Athni TS, Barmettler S

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2023; (130(6)):699-712 doi:10.1016/j.anai.2023.01.018.

    PMID: 36706910

This page is for informational purposes only and does not constitute medical advice about IMD99. An immunologist, hematologist, or genetic counselor should interpret your results and plan follow-up, especially if you receive immunoglobulin therapy.